Human Immunodeficiency Virus (HIV) Diagnostics Market Size is Expected to Reach USD 2,234.9 Million in 2030 - Rising Demand from Southern African Countries due to Increasing Prevalence of HIV is Driving Growth of Industry

The global Human Immunodeficiency Virus (HIV) diagnostics market size is expected to reach USD 9.02 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data.

The global Human Immunodeficiency Virus (HIV) diagnostics market size is expected to reach USD 9.02 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data. Rapid advancements in the healthcare sector for the development of innovative and self HIV diagnostics kits are driving global HIV diagnostics market revenue growth.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4134

Various approaches for HIV prevention include testing and counseling for sexually transmitted infections (STIs) and HIV, elimination of mother-to-child transmission, and use of therapies and antiretroviral drugs for prevention. The emergence of Point-of-Care (POC) testing in HIV diagnosis has led to the healthcare industry leveraging new innovations in POC instruments via R&D. POC devices are easy to operate and maintain and can be transported conveniently. Recent advancements in POC testing has resulted in the development of antiretroviral therapy (ART), Cluster of Differentiation 4(CD4) tests, HIV Rapid Diagnostic Tests (RDTs), Viral Load (VL) testing, and HIV early-infant diagnosis tests. Moreover, rising need for HIV testing kits and increase in research and development activities in countries such as India, China, and Indonesia are factors expected to boost growth of the market during the forecast period.

However, limited access and high cost of HIV diagnostics methods in underdeveloped and low-income countries are factors expected to hamper market growth during the forecast period.

Some Key Highlights from the Report

    • Software & services segment is expected to register rapid growth rate during the forecast period. Increasing demand for Machine Learning (ML) and Artificial Intelligence (AI) has led private companies to adopt diagnostics measures using software that not only helps to keep a record of the data and diagnostics reports of several people but also can locate individuals who are suffering from the disease, which in turn help government and other organization to provide help and assistant to that individual in a short span of time.
    • Antibody tests segment accounted for largest market revenue share in 2021 and is expected to register rapid growth rate during the forecast period owing to increasing technological advancements in HIV diagnosis products, growing awareness about HIV and its related diseases, and increasing blood donations in hospitals and blood donation camps. Antibody tests search for antibodies in the blood or oral fluid to fight HIV. Antibody tests take around 23 to 90 days to detect HIV infection after exposure.
    • HIV diagnostics market in North America accounted for largest revenue share in 2021 owing to presence of well-established healthcare infrastructure and HIV diagnostics kit manufacturing companies in this region. Moreover, increasing awareness among the younger generation and increasing investment by the government and private players in research activities for the development of HIV diagnostics kits are factors expected to boost market growth during the forecast period.
    • In February 2022, Siemens Healthineers and the United Nations Children’s Fund (UNICEF) announced partnership, which will help to optimize Point-of-Care (POC) diagnostics networks and strengthen fragile health systems in sub-Saharan Africa by improving access to diagnostics and linkage to treatment. Together UNICEF and Siemens Healthineers will fight to prevent maternal, newborn, and child deaths and common infectious diseases such as early infant HIV, COVID-19, and tuberculosis, which will promote the health and development of all children.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Siemens, F. Hoffman-La Roche Ltd., Abbott, Danaher, Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hologic, Inc., Bioneer Corporation, and Bio-Rad Laboratories, Ltd.

To know more about the report, visit @ https://www.reportsanddata.com/press-release/global-hiv-diagnostics-market

HIV Diagnostics Market Segmentation:

Product Outlook (Revenue, USD Million; 2019–2030)

  • Consumables
  • Instruments
  • Software & Services

End use Outlook (Revenue, USD Million; 2019–2030)

  • Hospitals
  • Home Care Settings
  • Diagnostics Laboratories
  • Blood Banks
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4134

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data:

Hyperimmune Globulins Market Size, Growth & Analysis, By Type By (Immunoglobulins for Hepatitis B, Immunoglobulins For Rabies, Immunoglobulins for Tetanus, Rho (D) Immunoglobulins, Others), End-Use (Government Institutions, Private Sector, Others), By Region, Forecast To 2027

Immune Globulin Intravenous Market Size, Trends & Analysis, By Product Type (IVIg Liquid, IVIg Powder), By Application (Immunodeficiency, Autoimmune Disease, Acute Infection), By Region, Forecast To 2027

UV Infection Control Device Market Size, Growth & Analysis, By Type (Mobile, Stationary, Others), By End User (Hospital, Clinics, Others), By Region, Forecast To 2027

Titanium Dental Implants Market Size, Share & Analysis, By Procedure (Two-Stage Procedure, Single-Stage Procedure), By End Use (Hospitals & Clinics, Dental Laboratories, Other Facilities), By Region, Forecast To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs